Eurofound's EU PolicyWatch collates information on the responses of government and social partners to the COVID-19 crisis, the war in Ukraine, rising inflation, as well as gathering examples of company practices aimed at mitigating the social and economic impacts.
Factsheet for measure DK-2020-13/1600 – Updated – measures in Denmark
| Country | Denmark , applies nationwide |
| Time period | Temporary, 23 March 2020 – 10 July 2021 |
| Context | COVID-19 |
| Type | Other initiatives or policies |
| Category |
Reorientation of business activities
– Change of production/Innovation |
| Author | Carsten Jørgensen (FAOS, University of Copenhagen), Anders Randrup (Oxford Research) |
| Measure added | 16 December 2020 (updated 19 December 2024) |
On 12 March 2020, the Danish Prime Minister, Mrs. Mette Frederiksen announced that due to the rapid spread of the corona virus, all economic life and educational functions would close down for a period of two weeks, which in the end were prolonged several times. Shortly after, the government and the social partners concluded a tripartite agreement on a comprehensive wage compensation scheme for furloughed employees that would otherwise have lost their jobs. In some cases, companies succeeded in reorganizing their production into producing personal protective equipment such as hand disinfectant and face shields. In order to use and secure this potential the state and the Confederation of Danish Industry established a cooperation with the aim to find and encourage companies to change their production, if possible, to items that would benefit a severely pressed health care sector and hospital personnel.
After the lockdown of economic and educational activities on 12 March 2020 due to the rapid spread of corona virus, the Danish health sector, and in particular the hospitals, were in acute need of protective equipment for the personnel. Therefore, in order to be able to cope with the pressure at the hospitals, the Danish Medicines Agency (Lægemiddelstyrelsen) encouraged the industrial companies in Denmark to switch over parts of the Danish industrial production to the much-needed personal protective equipment. This was in particular gloves, lab coats, isolation clothes, face shields, surgical masks, hand disinfectant and important equipment for COVID-19 tests.
Thus, on 23 March 2020 the Danish Medicines Agency launched a campaign, Denmark helps Denmark, in cooperation with the pharmaceutical industry and the influential employer and business interest associations, Confederation of Danish Industry, DI, and the Danish Chamber of Commerce, Dansk Erhverv, with the aim to coordinate the efforts of producing personal protective equipment in Danish industrial companies. On 27 March, the medicines agency announced that they had received more than 1,000 applications. DI will be the coordinator of the cooperation that also include the municipalities and regions. DI will systematise the companies and make sure to bring them in contact with the right authority, in order to ensure a correct assessment of the potential in the production reorganisation.
The following updates to this measure have been made after it came into effect.
| 10 July 2021 |
The ‘Denmark helps Denmark’ initiative, which was launched by the Danish Medicines Agency in March 2020 to encourage Danish companies to switch production to protective equipment during the COVID-19 pandemic, is no longer active. The campaign ended its activity after the urgent need for protective equipment was met and more than 2,000 companies had signed up. Coordination was then handed over to municipalities and regions, while the Danish Medicines Agency announced that it would no longer process new applications. The initiative fulfilled its purpose of supporting the healthcare sector during a critical period, but there is no indication that this collaboration or similar initiatives continue today. The Confederation of Danish Industry and other involved parties have returned to their normal activities. |
When the applications to the campaign ‘Denmark helps Denmark’ reached 2,000, the Danish Medicines Agency announced that the municipalities and regions had taken over the coordination of the procurements and future applications. The agency itself would therefore not deal with further applications. No other figures on the further use of the measure are available.
| Workers | Businesses | Citizens |
|---|---|---|
| Does not apply to workers |
SMEs
|
Does not apply to citizens |
| Actors | Funding |
|---|---|
|
Company / Companies
|
National funds
|
Social partners' role in designing the measure and form of involvement:
| Trade unions | Employers' organisations | |
|---|---|---|
| Role | No involvement | Agreed (outcome) incl. social partner initiative |
| Form | Not applicable | Direct consultation outside a formal body |
Social partners' role in the implementation, monitoring and assessment phase:
The Danish Medicines Agency contacted the employer organisations DI and Dansk Erhverv with the proposal to switch parts of the industrial production to produce protective equipment. To this end, the employer organisations should contact their companies. DI was chosen as coordinator of the efforts.
The social partners' views on / and reaction to the measure were positive and supportive.
This case is sector-specific (only private sector)
| Economic area | Sector (NACE level 2) |
|---|---|
| C - Manufacturing | C11 Manufacture of beverages |
| C13 Manufacture of textiles | |
| C14 Manufacture of wearing apparel | |
| C17 Manufacture of paper and paper products | |
| C20 Manufacture of chemicals and chemical products | |
| C21 Manufacture of basic pharmaceutical products and pharmaceutical preparations | |
| C22 Manufacture of rubber and plastic products |
This case is not occupation-specific.
Citation
Eurofound (2020), The state and Danish industry establish cooperation on companies' reorganisation to production of protective equipment, measure DK-2020-13/1600 (measures in Denmark), EU PolicyWatch, Dublin, https://static.eurofound.europa.eu/covid19db/cases/DK-2020-13_1600.html
Share
All publications are available on the EU PolicyWatch landing page .
Disclaimer: This information has not been subject to the full Eurofound evaluation, editorial and publication process.